Prevalence of Clostridium difficile infections among Kenyan children with diarrhea

International Journal of Infectious Diseases

Volumn 81, Issue , 2019, Pages 66-72

  Plants Paris, Kimberly ^a   Bishoff, Dayna ^a   Oyaro, Micah O ^b   Mwinyi, Bakari ^c   Chappell, Cynthia ^a   Kituyi, Adelaide ^c   Nyangao, James ^d   Mbatha, Daud ^c   Darkoh, Charles ^a,e  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF NAIROBI   (Kenya)

^c KENYATTA NATIONAL HOSPITAL   (Kenya)

^d KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^e UNIVERSITY OF TEXAS   (United States)

Author keywords

C. difficile co infection; C. difficile epidemiology; C. difficile pathogenesis; CDI in infants; CDI in young children; Clostridium difficile infections in Africa

Indexed keywords

BACTERIAL DNA; BACTERIAL RNA; CLOSTRIDIUM TOXIN; GENOMIC DNA; RNA 16S; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL GENE; BACTERIUM CULTURE; CHILD; CHILD HOSPITALIZATION; CLOSTRIDIUM; CLOSTRIDIUM DIFFICILE INFECTION; CRYPTOSPORIDIOSIS; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; FEMALE; FRAMESHIFT MUTATION; GIARDIA INTESTINALIS; GIARDIASIS; HUMAN; INFANT; INFECTIOUS DIARRHEA; KENYAN; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NEWBORN; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PREVALENCE; ROTAVIRUS INFECTION; SCHOOL CHILD; TCDA GENE; TCDB GENE; TCDC GENE; VIRUS DETECTION; YOUNG ADULT; CLOSTRIDIUM INFECTION; DIARRHEA; FECES; HEALTH SURVEY; ISOLATION AND PURIFICATION; KENYA; MICROBIOLOGY; PEPTOCLOSTRIDIUM DIFFICILE;

ANTI-BACTERIAL AGENTS; CHILD, PRESCHOOL; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DIARRHEA; FECES; FEMALE; HEALTH SURVEYS; HUMANS; INFANT; INFANT, NEWBORN; KENYA; MALE; POLYMERASE CHAIN REACTION; PREVALENCE;

EID: 85061776153     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2019.01.024     Document Type: Article

References (42)

1. Albert, M.J., Faruque, A.S., Faruque, S.M., Sack, R.B., Mahalanabis, D., Case-control study of enteropathogens associated with childhood diarrhea in Dhaka, Bangladesh. J Clin Microbiol 37:11 (1999), 3458–3464.
2. Alcides, A.P., Brazier, J.S., Pinto, L.J., Balassiano, I.T., Boente, R.F., de Paula, G.R., et al. New PCR ribotypes of Clostridium difficile detected in children in Brazil: prevalent types of Clostridium difficile in Brazil. Antonie van Leeuwenhoek 92:1 (2007), 53–59.
3. Carter, G.P., Douce, G.R., Govind, R., Howarth, P.M., Mackin, K.E., Spencer, J., et al. The anti-sigma factor TcdC modulates hypervirulence in an epidemic BI/NAP1/027 clinical isolate of Clostridium difficile. PLoS Pathog, 7(10), 2011, e1002317.
4. Checkley, W., Buckley, G., Gilman, R.H., Assis, A.M., Guerrant, R.L., Morris, S.S., et al. Multi-country analysis of the effects of diarrhoea on childhood stunting. Int J Epidemiol 37:4 (2008), 816–830.
5. Chen, S., Sun, C., Wang, H., Wang, J., The role of rho GTPases in toxicity of Clostridium difficile toxins. Toxins 7:12 (2015), 5254–5267.
6. Chitnis, A.S., Holzbauer, S.M., Belflower, R.M., Winston, L.G., Bamberg, W.M., Lyons, C., et al. Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011. JAMA Intern Med 173:14 (2013), 1359–1367.
7. Curry, S.R., Marsh, J.W., Muto, C.A., O'Leary, M.M., Pasculle, A.W., Harrison, L.H., tcdC genotypes associated with severe TcdC truncation in an epidemic clone and other strains of Clostridium difficile. J Clin Microbiol 45:1 (2007), 215–221.
8. Darkoh, C., DuPont, H.L., Kaplan, H.B., Novel one-step method for detection and isolation of active-toxin-producing Clostridium difficile strains directly from stool samples. J Clin Microbiol 49:12 (2011), 4219–4224.
9. Darkoh, C., Kaplan, H.B., Dupont, H.L., Harnessing the glucosyltransferase activities of Clostridium difficile for functional studies of toxins A and B. J Clin Microbiol 49:8 (2011), 2933–2941.
10. de Graaf, H., Pai, S., Burns, D.A., Karas, J.A., Enoch, D.A., Faust, S.N., Co-infection as a confounder for the role of Clostridium difficile infection in children with diarrhoea: a summary of the literature. Eur J Clin Microbiol Infect Dis 34:7 (2015), 1281–1287.
11. Elewa, A., Sayed-Zaki, M.E., Evaluation of nested polymerase chain reaction and immunoassay for rapid diagnosis of Clostridium difficile in children with community acquired diarrhea. Clin Lab 63:2 (2017), 321–326.
12. Emeruwa, A.C., Oguike, J.U., Incidence of cytotoxin producing isolates of Clostridium difficile in faeces of neonates and children in Nigeria. Microbiologica 13:4 (1990), 323–328.
13. Fiedoruk, K., Daniluk, T., Rozkiewicz, D., Zaremba, M.L., Oldak, E., Sciepuk, M., et al. Conventional and molecular methods in the diagnosis of community-acquired diarrhoea in children under 5 years of age from the north-eastern region of Poland. Int J Infect Dis 37 (2015), 145–151.
14. Fry, P.R., Thakur, S., Abley, M., Gebreyes, W.A., Antimicrobial resistance, toxinotype, and genotypic profiling of Clostridium difficile isolates of swine origin. J Clin Microbiol 50:7 (2012), 2366–2372.
15. Griffiths, D., Fawley, W., Kachrimanidou, M., Bowden, R., Crook, D.W., Fung, R., et al. Multilocus sequence typing of Clostridium difficile. J Clin Microbiol 48:3 (2010), 770–778.
16. Hundsberger, T., Braun, V., Weidmann, M., Leukel, P., Sauerborn, M., von Eichel-Streiber, C., Transcription analysis of the genes tcdA-E of the pathogenicity locus of Clostridium difficile. Eur J Biochem 244:3 (1997), 735–742.
17. Jangi, S., Lamont, J.T., Asymptomatic colonization by Clostridium difficile in infants: implications for disease in later life. J Pediatr Gastroenterol Nutr 51:1 (2010), 2–7.
18. Janssen, I., Cooper, P., Gunka, K., Rupnik, M., Wetzel, D., Zimmermann, O., et al. High prevalence of nontoxigenic Clostridium difficile isolated from hospitalized and non-hospitalized individuals in rural Ghana. Int J Med Microbiol 306:8 (2016), 652–656.
19. Khalil, I.A., Troeger, C., Rao, P.C., Blacker, B.F., Brown, A., Brewer, T.G., et al. Morbidity, mortality, and long-term consequences associated with diarrhoea from Cryptosporidium infection in children younger than 5 years: a meta-analyses study. Lancet Glob Health 6:7 (2018), e758–e768.
20. Kiulia, N.M., Kamenwa, R., Irimu, G., Nyangao, J.O., Gatheru, Z., Nyachieo, A., et al. The epidemiology of human rotavirus associated with diarrhoea in Kenyan children: a review. J Trop Pediatr 54:6 (2008), 401–405.
21. Kotloff, K.L., Nataro, J.P., Blackwelder, W.C., Nasrin, D., Farag, T.H., Panchalingam, S., et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet 382:9888 (2013), 209–222.
22. Leffler, D.A., Lamont, J.T., Clostridium difficile infection. New Engl J Med 372:16 (2015), 1539–1548.
23. Lemee, L., Dhalluin, A., Testelin, S., Mattrat, M.A., Maillard, K., Lemeland, J.F., et al. Multiplex PCR targeting tpi (triose phosphate isomerase), tcdA (Toxin A), and tcdB (Toxin B) genes for toxigenic culture of Clostridium difficile. J Clin Microbiol 42:12 (2004), 5710–5714.
24. Li, N., Jia, H., Yang, H., Ji, B., Liu, Y., Peng, X., et al. Preliminary screening of type IV secretion system in divergent geographic sources of Clostridium difficile. Exp Ther Med 14:5 (2017), 4405–4410.
25. Liu, L., Johnson, H.L., Cousens, S., Perin, J., Scott, S., Lawn, J.E., et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 379:9832 (2012), 2151–2161.
26. Liu, X.S., Li, W.G., Zhang, W.Z., Wu, Y., Lu, J.X., Molecular characterization of Clostridium difficile isolates in China from 2010 to 2015. Front Microbiol, 9, 2018, 845.
27. Mani, N., Dupuy, B., Regulation of toxin synthesis in Clostridium difficile by an alternative RNA polymerase sigma factor. Proc Natl Acad Sci U S A 98:10 (2001), 5844–5849.
28. Mani, N., Lyras, D., Barroso, L., Howarth, P., Wilkins, T., Rood, J.I., et al. Environmental response and autoregulation of Clostridium difficile TxeR, a sigma factor for toxin gene expression. J Bacteriol 184:21 (2002), 5971–5978.
29. Matamouros, S., England, P., Dupuy, B., Clostridium difficile toxin expression is inhibited by the novel regulator TcdC. Mol Microbiol 64:5 (2007), 1274–1288.
30. Murray, R., Boyd, D., Levett, P.N., Mulvey, M.R., Alfa, M.J., Truncation in the tcdC region of the Clostridium difficile PathLoc of clinical isolates does not predict increased biological activity of Toxin B or Toxin A. BMC Infect Dis, 9, 2009, 103.
31. Nicholson, M.R., Van Horn, G.T., Tang, Y.W., Vinje, J., Payne, D.C., Edwards, K.M., et al. Using multiplex molecular testing to determine the etiology of acute gastroenteritis in children. J Pediatr 176 (2016), 50–56 e2.
32. Nyaga, M.M., Stucker, K.M., Esona, M.D., Jere, K.C., Mwinyi, B., Shonhai, A., et al. Whole-genome analyses of DS-1-like human G2P[4] and G8P[4] rotavirus strains from Eastern, Western and Southern Africa. Virus Genes 49:2 (2014), 196–207.
33. Oyaro, M.O., Plants-Paris, K., Bishoff, D., Malonza, P., Gontier, C.S., DuPont, H.L., et al. High rate of Clostridium difficile among young adults presenting with diarrhea at two hospitals in Kenya. Int J Infect Dis 74 (2018), 24–28.
34. Pinto, L.J., Alcides, A.P., Ferreira, E.O., Avelar, K.E., Sabra, A., Domingues, R.M., et al. Incidence and importance of Clostridium difficile in paediatric diarrhoea in Brazil. J Med Microbiol 52:Pt 12 (2003), 1095–1099.
35. Rogawski, E.T., Bartelt, L.A., Platts-Mills, J.A., Seidman, J.C., Samie, A., Havt, A., et al. Determinants and impact of Giardia infection in the first 2 years of life in the MAL-ED birth cohort. J Pediatric Infect Dis Soc 6:2 (2017), 153–160.
36. Seugendo, M., Mshana, S.E., Hokororo, A., Okamo, B., Mirambo, M.M., von Muller, L., et al. Clostridium difficile infections among adults and children in Mwanza/Tanzania: is it an underappreciated pathogen among immunocompromised patients in sub-Saharan Africa?. New Microbes New Infect 8 (2015), 99–102.
37. Sigei, C., Odaga, J., Mvundura, M., Madrid, Y., Clark, A.D., Cost-effectiveness of rotavirus vaccination in Kenya and Uganda. Vaccine 33:Suppl. 1 (2015), A109–A118.
38. Squire, S.A., Ryan, U., Cryptosporidium and Giardia in Africa: current and future challenges. Parasit Vectors, 10(1), 2017, 195.
39. Troeger, C., Forouzanfar, M., Rao, P.C., Khalil, I., Brown, A., Reiner, R.C., et al. Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Infect Dis 17:9 (2017), 909–948.
40. Wang, L., Xiao, L., Duan, L., Ye, J., Guo, Y., Guo, M., et al. Concurrent infections of Giardia duodenalis, Enterocytozoon bieneusi, and Clostridium difficile in children during a Cryptosporidiosis outbreak in a pediatric hospital in China. PLoS Negl Trop Dis, 7(9), 2013, e2437.
41. Warny, M., Pepin, J., Fang, A., Killgore, G., Thompson, A., Brazier, J., et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366:9491 (2005), 1079–1084.
42. Wendt, J.M., Cohen, J.A., Mu, Y., Dumyati, G.K., Dunn, J.R., Holzbauer, S.M., et al. Clostridium difficile infection among children across diverse US geographic locations. Pediatrics 133:4 (2014), 651–658.